Connecture, Inc. to Present at the J.P. Morgan Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Connecture, Inc. to Present at the J.P. Morgan Healthcare Conference

BROOKFIELD, Wis., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Connecture, Inc. (NASDAQ: CNXR ), a provider of web-based information systems used to create health insurance marketplaces, today announced that Jeff Surges, Connecture's chief executive officer, and James Purko, the company's chief financial officer, will present at the 34 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14 th , 2016 at 7:30 a.m. PT (10:30 a.m. ET) at the Westin St. Francis Hotel in San Francisco.

The presentation will be available via live webcast and also available under the "News and Events" section on the Connecture investor relations website at Connecture Investor Relations .

About Connecture

Connecture (NASDAQ: CNXR ) is a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. Connecture’s customers are health insurance marketplace operators such as health plans, brokers and exchange operators, who must distribute health insurance in a cost-effective manner to a growing number of insured consumers. Connecture’s solutions automate key functions in the health insurance distribution process, allowing its customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.

Media Contact: Carolyn Edwards ReviveHealth 615-760-3681 ce@thinkrevivehealth.com Investor Relations Contact: Peter Vozzo Westwicke Partners 443-213-0505 peter.vozzo@westwicke.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading